Kemp Dolliver, CFA, is a seasoned healthcare finance executive with extensive experience across capital markets, encompassing both buy-side and sell-side roles in the United States and emerging Asia. He focuses on the biopharma and healthcare services sectors, bringing a deep understanding of investment strategies and market dynamics. Currently, he serves as the Senior Analyst and Director of Research at Brookline Capital Markets, a position he has held since 2021.